Browsing by Author Kim, WS

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 3 to 15 of 15 < previous 
TitleAuthor(s)Issue DateViews
 
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: A study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Journal:Blood
Au, WYWeisenburger, DDIntragumtornchai, TNakamura, SKim, WSSng, IVose, JArmitage, JOLiang, R
2009
121
 
Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission
Journal:American Journal of Hematology
Au, WYKim, SJYiu, HHYNgan, RKCLoong, FKim, WSKwong, YL
2010
155
 
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study
Journal:Journal of Hematology & Oncology
Huang, HZhu, JYao, MKim, TMYoon, DHCho, SGEom, HSLim, STYeh, SPSong, YKwong, YLKim, JSJin, JShi, YKim, HQing, MZhou, TGao, GDong, ZQi, MKim, WS
2021
17
 
Histone H3K27 Demethylase JMJD3 in Cooperation with NF-κB Regulates Keratinocyte Wound Healing
Journal:Journal of Investigative Dermatology
Na, JLee, KNa, WShin, JYLee, MJYune, TYLee, HWJung, HSKim, WSJu, BG
2016
66
 
Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
Journal:The Lancet Oncology
Kwong, YLAnderson, BOAdvani, RKim, WSLevine, AMLim, ST
2009
151
 
Nasal natural killer/T-cell lymphoma
Book:Extranodal lymphomas: pathology and management
Au, WYLiang, RHSKo, YHKim, WS
2008
135
 
Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
Journal:Cancer Science
Yamaguchi, MSuzuki, RKwong, YLKim, WSHasegawa, YIzutsu, KSuzumiya, JOkamura, TNakamura, SKawa, KOshimi, K
2008
157
 
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal Natural Killer (NK)/T-cell lymphoma, nasal type: The NK-cell tumor study group study
Journal:Journal of Clinical Oncology
Yamaguchi, MKwong, YLKim, WSMaeda, YHashimoto, CSuh, CIzutsu, KIshida, FIsobe, YSueoka, ESuzumiya, JKodama, TKimura, HHyo, RNakamura, SOshimi, KSuzuki, R
2011
151
 
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis
Journal:The Lancet Haematology
Kim, SJChoi, JYHyun, SHKi, CSOh, DAhn, YCKo, YHChoi, SJung, SHKhong, PLTang, TYan, XLim, STKwong, YLKim, WSAsia Lymphoma Study Group
2015
93
 
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Journal:Blood
Kwong, YLKim, WSLim, STKim, SJTang, TTse, EWCLeung, AYHChim, JCS
2012
89
 
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
Journal:Journal of Hematology & Oncology
Yoon, DHCao, JChen, TYIzutsu, KKim, SJKwong, YLLin, TYThye, LSXu, BYang, DHKim, WS
2020
17
 
Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group
Journal:American Journal of Hematology
Tse, EGill, HLoong, FKim, SJNG, SBTang, TKo, YHChng, WJLim, STKim, WSKwong, YL
2012
170
 
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
Journal:Leukemia
Lim, JQHuang, DTang, TTan, DLaurensia, YPeng, RJWong, EKYCheah, DMZChia, BKHIqbal, JGrigoropoulos, NFNairismägi, MLNg, CCYRajasegaran, VHong, HKim, SJCho, JTse, EMow, BCai, QCPoon, LMCai, QQTan, JChan, JYLim, JXGoh, YTPhipps, CRötzschke, OCheng, CLHa, JCHKhoo, LPLoh, YSMAu Yeung, RChan, TSYKwong, YLHwang, WKim, WSBei, JXLin, TOng, CKLim, ST
2020
48
Showing results 3 to 15 of 15 < previous